A method for dynamically estimating a biological effect of a variable combination of non-photon radiation in accordance with a relative biological effectiveness, RBE, model including at least one biological effect multiplier δ(T, E) which depends on particle type T and/or particle energy E, the method comprising: obtaining one or more non-photon radiation contributions D.sup.(i)(T, E), 1 ≤ i ≤ N, at least one of said contributions including multiple particle types and/or multiple particle energies; storing per-contribution dose-weighted averages δ̅.sup.(i), 1 ≤ i ≤ N, of said at least one biological effect multiplier with respect to each of the one or more contributions; and in response to obtaining an assignment Π of the combination, the assignment being in terms of non-negative coefficients k.sub.1, k.sub.2, ..., k.sub.N ≥ 0 to be applied to the one or more contributions, determining a biological effect of the combination, including computing a combined dose-weighted average δ̅.sup.Π of said at least one biological effect multiplier on the basis of the stored per-contribution dose-weighted averages.

A particle-accelerator diagnostic technology capable of evaluating extraction efficiency of charged particles in a short cycle is provided.

A diagnostic device for a particle accelerator includes: a first receiver configured to receive a first detection signal from a first detector that detects a first current value generated by movement of charged particles in a circular accelerator, the first detection signal being outputted as a signal corresponding to the first current value; a second receiver configured to receive a second detection signal from a second detector that detects a second current value generated by movement of charged particles extracted from the circular accelerator into a beam transport system, the second detection signal being outputted as a signal corresponding to the second current value; and a calculator configured to calculate an extraction efficiency of charged particles based on the first and second detection signals.

A system for determining a treatment plan in active ion beam treatment, to minimize unwanted dose, while maintaining or improving target dose coverage, whereby a beam is split into at least two sub-beams and where each sub-beam has a range shifter of different settings.

An isochronous cyclotron including one or more coils and a plurality of pairs of bulk superconductor sectors. The one or more coils can be configured to generate a magnetic field in the beam chamber having a magnetic flux density that increases radially from the central axis of the beam chamber, and is orientated substantially perpendicular to the median acceleration plane of the beam chamber. Each pair of bulk superconductor sectors can be disposed on opposite sides of the median acceleration plane. The plurality of pairs of bulk superconductor sectors can be configured to guide or concentrate the magnetic field to provide an axial focusing component of the magnetic field.

A treatment device includes a pulsed particles accelerator and a processor for controlling the latter to deliver a treatment plan by deposition at HDR of charged particles into a flash volume (Vht) by PBS. To shorten the time for depositing a target dose (Dti) into the cells spanned by the flash spots (Si) of the flash volume (Vht), the flash spots are combined into k sets of n flash spots (Si). After depositing a j.sup.th pulse dose (Dij) into the cells spanned by a i.sup.th flash spot (Si) the beam commutes from the ith flash spot (Si) to a next (i+1)th flash spot according to a flash scanning subsequence to deposit a jth dose into the cells spanned by each of the subsequent flash spots of the flash scanning subsequence, until returning to the ith flash spot to deposit a (j+1)th dose (Di(j+1)), and so on When all the cells spanned by all the flash spots of a set have received their corresponding target dose, the beam moves to a next set of combined flash spots and repeats the foregoing pulse deposition steps.

An example particle therapy system includes a toroid-shaped gantry having a central axis. The toroid-shaped gantry has a cover. The cover includes one or more segments that are rotatable at least partly around the central axis of the toroid-shaped gantry to create an unobstructed opening in the toroid-shaped gantry. The particle therapy system includes a patient couch configured to move relative to a hole in the toroid-shaped gantry, an imaging system coupled to an interior of the toroid-shaped gantry and configured for rotation about the hole in the toroid-shaped gantry, where the imaging system is configured to capture images of a patient on the patient couch, and a nozzle coupled to the interior of the toroid-shaped gantry and configured for rotation about the hole in the toroid-shaped gantry. The nozzle is configured to deliver radiation to a target in the patient based on one or more of the images.

A beam shaping assembly (10) used in a neutron capture system and capable of changing an irradiation range of a neutron beam. The beam shaping assembly includes: a beam inlet (11), a target (12), a moderator (13) adjoining the target (12), a reflector (14) surrounding the moderator (13), a thermal neutron absorber (15) adjoining the moderator (13), a radiation shield (16) arranged inside the beam shaping assembly (10), and a beam outlet (17). The beam shaping assembly (10) further includes replacement components (21, 22) that can be attached to and detached from the beam shaping assembly (10) to change the irradiation range of the neutron beam.

A treatment planning system for generating a plan for treatment by radiation with charged particles beams applied by pencil beam scanning onto a target tissue comprising tumoral cells is provided. The treatment planning system performs a dose definition stage defining the doses to be deposited within the peripheral surface, a beam definition stage defining positions and dimensions of the beamlets of the PBS during the at least one high rate fraction, the beams definition stage including a dose rate definition stage comprising at least one high rate fraction, and a beamlets scanning sequence stage defining a scanning sequence of irradiation of the beamlets. The beamlets scanning sequence stage optimizes a time sequence of beamlets emission such that at the end of a fraction j, a dose is deposited onto at least a predefined fraction of each specific volume at a mean deposition rate superior or equal to a predefined value.

Methods and systems are described for determining quantities of interest for particle therapy. An example method can comprise determining one or more first functions indicative of spectral fluence associated with a particle therapy. The one or more first functions can be based on a plurality of simulations of a particle beam. The method can comprise determining, based on the one or more first functions and a second function associated with calculating a quantity, data indicative of the quantity. The method can comprise causing output of the data indicative of the quantity.

A system and method for delivering radiation therapy to a patient includes generating a radiation therapy plan and adjusting a shape of at least one of a plurality of multi-leaf collimators (MLCs) arranged in an arc about a patient bed to create a respective plurality of desired beam profiles for each of the plurality of MLCs to thereby implement the ultrafast radiation therapy plan delivery. The method further includes control a radiation therapy source to execute the radiation therapy plan by creating the respective plurality of desired beam profiles for each of the plurality of MLCs.